InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by David Redfern, President, Corporate Development. Director active across 1 companies, notably GSK plc. Cumulatively, 1 reports have been logged. The latest transaction was disclosed on 12 May 2026 — Purchase. Regulator: RNS (LSE). All data is openly available.
Declarations1 total
£30114 shares@ £21.51210.0000% mcap100.0% of flow
London Stock Exchange (XLON)
RNS:9569357-3·
Ideal exit: 6 Feb 2027 (T+270)
1 of 1 declaration
About David Redfern
David Redfern is the Chief Executive Officer and Head of Corporate Development at GSK plc. In this role, he oversees the company's growth and expansion initiatives. His experience in the pharmaceutical sector enables him to guide the company towards new opportunities.
